PD1 Reports

The Prescribing Services Unit is responsible for the reimbursement and remuneration to all dispensing contractors that are registered in Wales. Payment is made for those drugs prescribed on FP10.

The Drug Tariff determines what is paid to contractors for the services they provide. This includes reimbursement (the cost of the drugs, appliances etc.) and remuneration (fees, allowances etc.). The total sum is paid each month and can differ depending on the type of dispensing contractor.

The PD1 report provides statistical data relating to prescriptions dispensed in Wales aggregated by dispensing contractor type for each Local Health Board.

The documents listed below contain all seven reports for each month.

For a detailed description of the reports see the User Guide in the Key Documents section.

FAQs

How do I contact you?

You can contact us by phone, email or post. Visit our Contact Us page for further information

Why have we moved to automated prescription processing?

Automated processing allows us to improve the accuracy of reimbursement to contractors by reducing the potential for human error. Our accuracy rate has improved from 99.15% to 99.54% since the introduction of automated processing.

It also improves our efficiency, making a significant contribution to: -

Our ability to continue to reimburse contractors in accordance with SLA timescales in the face of ever increasing prescription volumes
Our ability to release funds to be reinvested in front line NHS services. We process 47% more prescription items with 53% fewer staff since the inception of our automation programme.

Medicines Use Review & Prescription Interventions - what is the difference?

A number of queries have been raised by pharmacists regarding the differentiation between MURs and prescription intervention MURs. To clarify the matter Welsh Government has confirmed that there is only one service (i.e. the MUR service) but the service may be prompted in different ways.

Regular MURs can be prompted pro-actively by identification of a certain group of patients that subsequently lead to an invitation for a Medicines Use Review.

A prescription intervention MUR is more reactive, in the sense that it is the response to a significant adherence problem with a person's medication that subsequently leads to an MUR being conducted. This is distinct from pharmacists making clinical interventions on prescriptions (e.g. where an interaction is identified and there is a need to get a prescription amended) which are required by the terms of service for all pharmacy contractors.

Get in Touch

If you have a query for our Primary Care Services. Please contact us below: